FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved Allergan, Inc.'s supplemental application for OXYTROL (oxybutynin). This action updates the product's labeling and/or indications under a suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• OXYTROL (OXYBUTYNIN)

Snippet

SUPPL AP for OXYTROL (OXYBUTYNIN)